-+ 0.00%
-+ 0.00%
-+ 0.00%

ArriVent Biopharma Showcases Global Oncology Pipeline and Late-Stage Firmonertinib Program in New Presentation

Reuters·11/11/2025 14:39:01

Please log in to view news